Sie sind auf Seite 1von 5

CAPITOL UNIVERSITY COLLEGE OF NURSING Name of Student : Name of Patient:_______________ __________________________ Date of Assignment:______________ Ward:________________________Bed No.

DRUG ORDER (Generic name, brand name,


classification, dosage, route, frequency)

MECHANISM OF ACTION

iNDICATIONS

CONTRAINDICATIONS

ADVERSE EFFECTS OF THE DRUG

NURSING RESPONISBILITIES

Generic name: lidocaine Brand name: Lidamantle Classification: Anesthetic Dosage: 1ml Route: IM/topical Frequency:

Lidocaine suppresses the automaticity and spontaneous depolarization of the ventricles during diastole by altering the flux of sodium ions across the cell membrane with little or no effect on the heart. Locally, it produces local anesthesia effect by inhibiting the transport of ions across the neural membranes. Thus, initiation and conduction of normal nerve impulses is prevented.

*Intravenous ventricular arrhythmias *Intramuscular selfinjected or when IV is unavailable during transport to local facilities *Local infiltration or mucosal or topical anesthetic *Patch used when pain is present due to postherpetic neuralgia

Hypovolaemia; heart block or other conduction disturbances.

Dizziness, paraesthesia, drowsiness, confusion, respiratory depression and convulsions.

When Lidocaine is administered as an antiarrhythmic the nurse should monitor the ECG continuously. Blood pressure and respiratory status should be monitored frequently during the drug administration. When administered as

an anesthetic, the numbness of the affected part should be assessed. Serum Lidocaine levels should be monitored frequently during prolonged use. Therapeutic serum lidocaine levels range from 1.5 to 5 mcg/ml. If signs of overdose occur (listed above), stop the infusion immediately and monitor the patient closely.

DRUG ORDER (Generic name, brand name,


classification, dosage, route, frequency)

MECHANISM OF ACTION

iNDICATIONS

CONTRAINDICATIONS

ADVERSE EFFECTS OF THE DRUG

NURSING RESPONISBILITIES

Generic name: Tetanus immunoglobulin(human) Brand name: Classification: Vaccines Dosage: 250 units Route: IM Frequency:

Tetanus immunoglobulin is used for passive immunisation against tetanus. Absorption: Well absorbed.

Tetanus prophylaxis. Tetanus treatment.

Must not be given IV as patient could develop shock. Should not be given in severe thrombocytopenia & in hemostasis.

Chills, headache, fever, nausea, vomiting, allergic reactions, dizziness, low BP, arthralgia & moderate low back pain.

Remove the prefilled syringe from the package. Lift syringe by barrel, not by plunger. Twist the plunger rod clockwise until the threads are seated. With the rubber needle shield secured on the syringe tip, push the plunger rod forward a few millimeters to break any friction seal between the rubber stopper and the glass syringe barrel. Remove the needle shield and expel air bubbles. [Do not remove the rubber needle shield to prepare the product for administration until immediately prior to the anticipated injection time.] Proceed with hypodermic needle puncture. Aspirate prior to injection to confirm that the needle is not in a vein or artery. Inject the medication.

Keeping your hands behind the needle, grasp the guard with free hand and slide forward toward needle until it is completely covered and guard clicks into place. If audible click is not heard, guard may not be completely activated. Place entire prefilled glass syringe with guard activated into an approved sharps container for proper disposal.

CAPITOL UNIVERSITY COLLEGE OF NURSING Name of Student : Name of Patient:_______________ __________________________ Date of Assignment:______________ Ward:________________________Bed No.

DRUG ORDER (Generic name, brand name,


classification, dosage, route, frequency)

MECHANISM OF ACTION

iNDICATIONS

CONTRAINDICATIONS

ADVERSE EFFECTS OF THE DRUG

NURSING RESPONISBILITIES

Generic name: favirab Brand name: Lidamantle Classification: Vaccines Dosage: 40 iu/kg Route: IM Frequency:

Used in a postexposure prophylaxis regimen that includes active immunizatio n with rabies vaccine and passive immunization with RIG. RIG provides immediate, temporary rabies virus-neutralizing antibodies until the patient has an immunologic response to active immunization with rabies vaccine and produces virusneutralizing antibodies.

Seroprophylaxis in individuals exposed to rabies virus, particularly serious exposure (multiple severe bites to the face, head, neck & hands when domestic or wild animal incriminated either cannot be examined or is affected or suspected of being affected by rabies; bites in young childn).

Known history of allergic symptoms to equine proteins.

Immediate reactions: Anaphylactoid reactions w/ hypotension, dyspnea & urticaria. Delayed reactions: Serum sickness-like reactions may occur about 6 days after the beginning of treatment.

Do not administer RIG in the same syringe or at the same injection site as rabies vaccine. Do not administer IV.